LIM Homeobox Transcription Factor 1, beta (LMX1B) Peptide
Quick Overview for LIM Homeobox Transcription Factor 1, beta (LMX1B) Peptide (ABIN8104461)
Target
Source
Application
-
-
Purpose
- LMX1B Peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-LMX1B antibody ( ARP38140_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LMX1B (LIM Homeobox Transcription Factor 1, beta (LMX1B))
-
Background
-
Background Information: LMX1B is essential for the specification of dorsal limb fate at both the zeugopodal and autopodal levels. Defects in LMX1B are the cause of nail-patella syndrome (NPS) also knowan as Onychoosteodysplasia.
Alternative Symbols: NPS1, LMX1.2
-
Molecular Weight
- 42kDa
-
Gene ID
- 4010
-
NCBI Accession
- NP_002307
-
UniProt
- Q6ISC9
Target
-